BELLEVUE, Wash.--(BUSINESS WIRE)--CellCyte Genetics Corporation (OTCBB:CCYG) announced today that the Company has signed a beta test collaboration agreement with the Fred Hutchinson Cancer Research Center in Seattle, Washington, to evaluate the effectiveness of CellCyte’s CCG-E45 Culture Chamber product as a supplement or replacement to their current methods of culturing specific cell lines.
